The impact on investigator involvement post HREC/IRB notification of the clinical oversight committee recommendation is yet to be disclosed.
Presuming OncoSil are aware of and compliant with ethics reporting requirements. I am doubtful.
This is really going to hurt site and participant recruitment efforts. Almost certai that participants will withdraw on becoming aware of proven lack of clinical benefit.
No related updates on clinicaltrials.gov or ANZCT databases as yet. Watch this space.
- Forums
- ASX - By Stock
- OSL
- Ann: Update - CE Marking Application
Ann: Update - CE Marking Application, page-12
- There are more pages in this discussion • 122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.66M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $27.82K | 5.623M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
48 | 32306679 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 2990752 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
48 | 32306679 | 0.004 |
13 | 7852785 | 0.003 |
5 | 4457516 | 0.002 |
4 | 7800000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 2990752 | 2 |
0.006 | 17193449 | 18 |
0.007 | 23321915 | 19 |
0.008 | 5509148 | 8 |
0.009 | 7462253 | 4 |
Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
Last
0.5¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
0.5¢ | 0.5¢ | 0.5¢ | 1577500 | ||
Last updated 15.49pm 30/05/2024 ? |
Featured News
OSL (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online